Literature DB >> 2021845

Carcinoma of the rectum: a 10-year experience.

A R Dixon1, W A Maxwell, J T Holmes.   

Abstract

A consecutive series of 303 patients with carcinoma of the rectum and distal sigmoid colon treated by a single surgeon over a 10-year period are reported. Of these, 202 underwent an anterior resection, 85 an abdominoperineal excision of the rectum and 16 a coloanal anastomosis. Surgery was considered palliative in 52 patients undergoing anterior resection and 24 undergoing abdominoperineal resection. The 30-day hospital mortality rate was six patients (3 per cent) for anterior resection and two patients (2 per cent) for abdominoperineal resection. Peroperative anastomotic testing demonstrated leakage in five stapled anastomoses; these were rectified and no clinical sequelae occurred. Two patients (1 per cent) developed a clinical anastomotic leak, one of which proved fatal; in each case the intraoperative test was negative. The overall 5-year survival rate was 64 per cent after anterior resection and 52 per cent after abdominoperineal resection; the median follow-up was 64 months. The incidence of local pelvic recurrence was 6.4 per cent after anterior resection and 14 per cent after abdominoperineal (not significant). These results confirm the success of sphincter-saving anterior resection combined with total mesorectal excision, routine full mobilization of the splenic flexure and cancercidal lavage of the distal rectum in the treatment of low rectal carcinomas; morbidity, local recurrence and survival are not compromised.

Entities:  

Mesh:

Year:  1991        PMID: 2021845     DOI: 10.1002/bjs.1800780314

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  18 in total

1.  Total mesorectal excision for rectal cancer: the truth lies underneath.

Authors:  Jesús A Fernández-Represa; Julio M Mayol; Julio Garcia-Aguilar
Journal:  World J Surg       Date:  2004-01-08       Impact factor: 3.352

2.  Simplification of total mesorectal excision with colonic J-pouch anal anastomosis for middle and lower rectal cancer: one surgeon's experience.

Authors:  Masato Kusunoki; Yasuhiro Inoue; Hidenori Yanagi
Journal:  Surg Today       Date:  2008-07-31       Impact factor: 2.549

3.  Laparoscopic versus open surgery for extraperitoneal rectal cancer: a prospective comparative study.

Authors:  M Morino; M E Allaix; G Giraudo; F Corno; C Garrone
Journal:  Surg Endosc       Date:  2005-10-03       Impact factor: 4.584

4.  Surgeon-related factors and outcome in rectal cancer.

Authors:  G A Porter; C L Soskolne; W W Yakimets; S C Newman
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

5.  Omentoplasty in the prevention of anastomotic leakage after colonic or rectal resection: a prospective randomized study in 712 patients. French Associations for Surgical Research.

Authors:  F Merad; J M Hay; A Fingerhut; Y Flamant; J M Molkhou; Y Laborde
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

Review 6.  Analysis of local recurrence rates after surgery alone for rectal cancer.

Authors:  J L McCall; M R Cox; D A Wattchow
Journal:  Int J Colorectal Dis       Date:  1995       Impact factor: 2.571

7.  Computerised audit for colorectal cancer.

Authors:  D R Harriss; J R Blake
Journal:  Ann R Coll Surg Engl       Date:  1993-07       Impact factor: 1.891

Review 8.  Extended abdominoperineal excision vs. standard abdominoperineal excision in rectal cancer--a systematic overview.

Authors:  Sigmar Stelzner; Carsta Koehler; Juliane Stelzer; Anja Sims; Helmut Witzigmann
Journal:  Int J Colorectal Dis       Date:  2011-05-21       Impact factor: 2.571

Review 9.  Sphincter saving rectum resection is the standard procedure for low rectal cancer.

Authors:  E Di Betta; A D'Hoore; L Filez; F Penninckx
Journal:  Int J Colorectal Dis       Date:  2003-02-20       Impact factor: 2.571

Review 10.  Results of radical surgery for rectal cancer.

Authors:  R J Heald; N D Karanjia
Journal:  World J Surg       Date:  1992 Sep-Oct       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.